# Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion

> **NCT05791552** · NA · UNKNOWN · sponsor: **Noselab GmbH** · enrollment: 500 (estimated)

## Conditions studied

- Nasal Secretion
- Alzheimer Disease
- Brain Nose Interface

## Interventions

- **DIAGNOSTIC_TEST:** Collection of nasal secretion

## Key facts

- **NCT ID:** NCT05791552
- **Lead sponsor:** Noselab GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05791552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05791552, "Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05791552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*